Daily average lexicon sentiment across 202 scored headlines over the last 8 days. For market-wide mood (VIX, breadth, regime), see Markets. For the learned model that predicts forward return from a headline, see Headline Forecast Model.
Aeluma (NASDAQ:ALMU) said fiscal 2026 established a foundation for commercializing its photonics technology for artificial intelligence data-center interconnects, as the company expanded its workforce, strengthened manufacturing relationships and raised capital to support development. Founder and C
Chasing the biggest dividend yields can quietly sabotage long-term income, and three mega-cap businesses with some of the smallest payouts on the market reveal exactly why the math works against most income investors.
eBay (EBAY) has gained 5.4% over the past five trading days while the S&P 500 fell 1.3%. A stock rising in a falling market pulls money in. Five days say nothing about what a holding does to your money over the years you would own it. eBay's longer-term record presents a more mixed risk-adjusted picture.
International Business Machines (IBM) has risen 6.0% over the last five trading days while the S&P 500 fell 1.3%. A run like that in a weak market pulls money in, but the five-day move is not the question worth answering. What matters is what IBM does to your money when the market moves. Most of what IBM does has little to do with the market.
Micron's advanced DRAM packaging enables the 512GB DDR5 RDIMM to unlock data center performance with speeds up to 9,200 MT/s and reduced operating power by more than 60%BOISE, Idaho, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), today announced a major milestone in memory innovation with the successful demonstration of the world's first 512GB DDR5 module on multiple server platforms. The achievement reinforces Micron's leadership in high-performance, high-capacity serv
In September 2026, Atsign announced with Intel that they had removed a major encryption bottleneck for autonomous edge AI agents, reporting very large performance gains in secure agent-to-agent communications on Intel Xeon and Core Ultra 9 platforms and joining Intel’s Industrial Builders partner program. Intel’s work with Atsign underscores how hardware-rooted security and zero-trust architectures could make its CPUs more relevant as agentic AI expands into smart transportation and other...
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the defense contractors industry, including Northrop Grumman (NYSE:NOC) and its peers.
Coinbase Global (COIN) stock has gained about 18% over the past month, and it is still down about 44% over the past year. At about $175 a share, the market pays 7.3 times sales against 3.2 for the S&P 500, more than double the market's price for revenue that is shrinking. The question is whether what Coinbase is building is worth more than what it is losing.
Intuitive Surgical (ISRG) trades near $370, about 38% below its 52-week high, after growth in its US robotic-surgery procedures slowed. Selling a put pays you now for agreeing to buy the shares much lower, and you keep the payment either way. The catch is it only works if you would want this business at that price.
Forum Expands Ecosystem Readiness Alongside Groundbreaking Pre-Standard ISAC and Live Sports Companion MilestonesNEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Verizon today announced a major acceleration in the development of next-generation wireless architectures with the formal expansion of the Verizon 6G Innovation Forum (6GIF). Nine industry heavyweights—Amazon Web Services (AWS), Cisco, Intel, Keysight Technologies, MediaTek, NVIDIA, Palo Alto Networks, Rohde & Schwarz and VIAVI Solutions—ha
AUSTIN, Texas, September 14, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced that it has entered into a binding commitment with Sanabil (Cayman) for a senior unsecured revolving credit facility of up to US$30 million. The facility is intended to support MindWalk’s biologics programs, commercial expansion, working capital, and general corporate purposes.
CrowdStrike is generating record revenue and free cash flow while C3.ai works to rebuild from the ground up. The gap in execution between these two companies tells the whole story.
The facility is intended to support MindWalk’s biologics programs, commercial expansion, working capital, and general corporate purposes. The facility carries a fixed annual interest rate of 7.00%, accruing only on
Trump's promise of a $5,000 cash payment comes with a restriction no US transfer program has ever tried to enforce, and that single condition rewrites the math on what the money would actually be worth to you.
Arista published its batch of security advisories on September 9, turning an advance warning into an immediate customer maintenance task. The release includes critical vulnerabilities affecting EOS and VeloCloud. Cisco’s September 4 security commentary describes the broader problem: vulnerability discovery is accelerating beyond customers’ ability to remediate it. For Cisco Systems, Inc. (NASDAQ:CSCO) and Arista […]
Datadog (NASDAQ:DDOG) is investing in artificial intelligence capabilities, proprietary models and enterprise sales as it seeks to expand its observability platform’s role in monitoring increasingly complex cloud and AI workloads, Chief Financial Officer David Obstler said during a company session.
Three pipeline giants collect tolls on North American energy flows regardless of where crude prices land, but choosing the wrong one for your retirement account could quietly cost you more than the yield is worth.
AIâs doomsday headlines make great engagement, but the real investment edge lies in understanding the bottlenecks. Read more on the bottlenecks here.
Uber Technologies (UBER) generates free cash flow worth 6.8% of its market value a year, against 4.5% for the median S&P 500 company. A gap that wide usually points to a business the market expects to shrink. Uber is not shrinking; revenue grew 16.7% over the trailing twelve months. So the question is who gets the cash.
Freeport-McMoRan (FCX) stock fell 6.6% on Thursday to close at $71.21, while the S&P 500 slipped 0.6%. Copper sold off on surging yields and on reports that the White House has yet to decide on copper tariffs, raising concern the plan could be dropped over worries about higher manufacturing costs. That doubt lands on the part of Freeport that management says a tariff would help: its US business.
Two funds and a single brokerage screen sound like the easiest path to four-figure monthly income, but the number that determines whether this plan actually works is one most investors never think to check.
Shaw worked with all three of Microsoft's CEOs—Bill Gates, Steve Ballmer, and Satya Nadella— and has played a major role in shaping much of how Microsoft communicates to the outside world.
UiPath (PATH) sells software that brings AI agents, robots, and people together to run business processes. Its Q2 FY2027 results beat management's guidance and the fiscal 2027 outlook went up, yet the shares fell 16.6% on September 4, the first trading day after the report, while the S&P 500 slipped 0.4%. The earnings call also carried an analyst's question about a new AI model said to be far better at workflow jobs.
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Ahead of the midterms, election officials ban certain workers from using prediction markets to reassure the public they are committed to election integrity.
Snowflake (SNOW) stock has returned about 37% over the past three months, against 4.8% for the S&P 500, and trades about 8% below its 52-week high. The stock has gained more than 30% in under two months on 10 occasions since 2020, most recently in 2026, and six of those gains topped 50%. The case for another leg rests on what sits behind three straight quarters of faster growth: Snowflake's AI tools are getting customers to use more of its core data platform.
Treasury yields are making income investors work harder than they have in years, and most dividend stocks no longer clear the bar. Six still do, but yield alone is the easy part of the analysis.
Equity markets look resilient, but AI capex, weak housing, private credit stress and a negative equity risk premium signal dangerâread the outlook now.
Eaton (ETN) makes the power equipment that goes inside data centers, among much else, and it has climbed 5.0% over the last five trading days while the S&P 500 slipped 0.2%. A run like that pulls money in. The question worth answering is not where the stock goes from here. It is what owning Eaton does to the rest of your money every time the market moves, and it moves further than the index in both directions.
Accenture (ACN) produced free cash flow worth 11.7% of its market value over the last twelve months, against 4.4% for the median S&P 500 company. A yield that wide means one of two things: a bargain, or a business the market expects to shrink. Accenture sells its people's time, and the discount is a bet on what AI does to that.
“Too big to fail” is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their ability to find new sources of growth.
While the top- and bottom-line numbers for RH (RH) give a sense of how the business performed in the quarter ended July 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Not all dividend ETFs are built the same, and parking $100,000 in the wrong one could mean leaving thousands of dollars in annual income on the table compared to a better-matched alternative.
Register by September 11 to Save Before Registration Prices IncreaseROSEMONT, IL / ACCESS Newswire / September 10, 2026 / As artificial intelligence moves from experimentation to real-world applications across manufacturing, will bring together industry leaders, technology experts and manufacturing professionals for an extensive education program focused on the technologies, strategies and workforce issues shaping the future of the industry. The event will take place October 27-29, 2026, at the
Wall Street has long feared that new AI shopping agents are coming for Shopify But those worries could be overblown, says one analyst. Shares of Shopify have fallen 14% this month, according to Dow Jones Market Data. Smilek acknowledged that consumer AI agents like SpaceX’s Grok Bot and Meta’s Muse—which launched earlier this week—have weighed on Wall Street’s confidence in Shopify.
Cummins (NYSE:CMI) has outperformed the market over the past 10 years by 3.11% on an annualized basis producing an average annual return of 16.64%. Currently, Cummins has a market capitalization of $76.00 billion.
Brian Niccol marked two years of the "Back to Starbucks" plan by declaring the turnaround complete and outlining a renovation push for thousands of locations
If you hold Pfizer (PFE) or Zoetis (ZTS), you hold the same idea: a branded medicine becomes a standard of care and keeps earning for years, in people or in animals. That is where it stops. Pfizer is buying replacements for older drugs losing exclusivity. Zoetis is cutting its effective price to keep the franchises it has. Same bet, two opposite defenses.
Michael Burry just closed his most prominent AI short, the kind of move that typically sparks a relief rally, yet CoreWeave kept falling. What that silence signals about the real debate gripping the cloud trade right now is worth understanding before Oracle reports tonight.
Microsoft (MSFT) runs the highest operating margin in its peer group and grows revenue faster than every rival there but one. Over the past twelve months its stock returned -0.5%, against 18.5% for the S&P 500 (SPY). At about $491.65 a share, it trades at 27.8 times earnings, second-richest in the group. Microsoft ranks first on profitability and fourth on the return, a gap worth explaining.
Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to discuss a transformative agreement with Pfizer that significantly strengthens the company’s position in precision oncology and provides key resources to advance its lead cancer program. Under the development and licensing agreement, Medicus has secured rights to a CD228-targeted antibody-drug conjugate (ADC) program, while Pfizer is contributing approximately $2 million in development funding, along with inventory and infrastructure support. Bokhari described the transaction as a major milestone that effectively provides the company with the resources needed to continue development from where Pfizer concluded its Phase 1 dose-escalation work. The CD228-targeted ADC is being developed for the treatment of solid tumors, including refractory melanoma, and now represents the centerpiece of Medicus’ evolving oncology strategy. Bokhari said the agreement allows the company to move forward with a capital-efficient approach while leveraging the extensive scientific and clinical groundwork already completed by Pfizer. Beyond oncology, Medicus continues to make progress with its SkinJect program, which is focused on the treatment of basal cell carcinoma and related conditions. Bokhari noted that final clinical trial results recently published on ClinicalTrials.gov identified the 200-microgram patch as the optimal dose for future registrational studies. The company is now concentrating its efforts on advancing SkinJect in patients with Gorlin syndrome, a rare genetic condition that can lead to the development of multiple basal cell carcinomas throughout a patient’s lifetime. Medicus is preparing to move forward with the FDA-approved pivotal SkinJect 005 study while simultaneously recruiting patients for the trial. At the same time, Bokhari said the company is positioning the broader nodular basal cell carcinoma opportunity for potential out-licensing, allowing Medicus to focus internal resources on the areas where it sees the strongest risk-adjusted return. To support the commercial potential of SkinJect, Medicus commissioned an independent reimbursement analysis that suggests the treatment could potentially achieve reimbursement levels of $25,000 or more per patient. Bokhari noted that the rare disease and potential pediatric disease characteristics associated with Gorlin syndrome could provide attractive regulatory and commercial advantages. He described SkinJect as “partner-ready” and indicated that the company is actively exploring opportunities to unlock additional value through strategic partnerships. Bokhari characterized the Pfizer agreement as a paradigm shift for Medicus, transforming the company into a precision oncology-focused biotechnology business while maintaining a disciplined approach to capital allocation. He compared the strategy to a Berkshire Hathaway-style model for drug development, where resources are selectively deployed into programs with the highest potential returns. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #SkinJect #Pfizer #PrecisionOncology #Biotech #CancerResearch #ADC #Melanoma #DrugDevelopment #ClinicalTrials #SkinJect #GorlinSyndrome #Biotechnology #HealthcareInnovation #Oncology #LifeSciences
Omega Point, the portfolio intelligence platform - trusted by investment managers globally for over a decade, today announced the launch of Kelly, its AI agent for investment intelligence. Kelly is designed & built by market veterans, who have spent their careers getting it right. Working with Kelly feels like having a seasoned expert at your side, sharpening your thinking with every question. Ask it to dig in like an analyst, think through construction like a PM, challenge your assumptions like
Cathie Wood’s ARK Invest just made a portfolio move that begs a question about timing. Her firm bought 43,091 shares of Meta worth roughly $27.9 million across the ARK Innovation and Next Generation Internet ETFs, while selling 84,392 Alphabet shares valued at about $27.8 million through the same funds. The swap comes after META has […]
Alphabet just posted blowback earnings that crushed estimates across every major segment, yet the stock sits nearly 8% below last month's highs. Here is why that gap between operating momentum and share price could matter a lot to long-term investors.
CFO Preston Wells said at a healthcare conference that the company is still working through supply issues in its peripheral vascular business and had fewer hip sales than expected so far this quarter.
DuPont (NYSE: DD) today announced that, together with The Chemours Company ("Chemours"), and Corteva Inc. and its subsidiary EIDP Inc. (formerly known as E. I. du Pont de Nemours and Company and together with its parent, Corteva Inc., referred to as "Corteva"), it has entered into a settlement (the "Settlement") with the State of North Carolina and 11 local entities* in the vicinity of the Company's Fayetteville Works facility that were excluded from the U.S. Public Water System Class Settlement
The Chemours Company (NYSE: CC) (the "Company") today announced that, along with DuPont de Nemours, Inc. ("Dupont") and Corteva, Inc. ("Corteva"), it has entered into a settlement (the "Settlement") with the State of North Carolina (the "State") and 11 local entities* in the vicinity of the Company's Fayetteville Works facility that were excluded from the U.S. Public Water System Class Settlement approved in 2024.
Designer Brands Inc. (NYSE: DBI) (the "Company," "we," "us," "our," and "Designer Brands"), one of the world's largest designers, producers, and retailers of footwear and accessories, today announced financial results for the second quarter ended August 1, 2026.
SCHD dominates domestic dividend portfolios, but roughly half the world's quality payers never appear in a U.S. screen. Schwab built a companion fund applying the same rigorous filters to international markets, and the performance and yield numbers may surprise you.
FEATURE Shares of Chewy dropped Wednesday as the pet supplies retailer reported mundane quarterly earnings and raised its fiscal year sales outlook. Chewy stock closed down 10.8% to $20.75 on Wednesday, its largest daily percentage decline since Sept.
NEW YORK, September 09, 2026--American Express is kicking off its first season as the Official Payments Partner of the NFL with a range of experiences, access, benefits and perks to celebrate football fans and the excitement of the start of the 2026 NFL season.
Shares of Chewy dropped Wednesday as the pet supplies retailer reported mundane quarterly earnings and raised its fiscal year sales outlook. Net sales rose 7.3% to $3.33 billion, in line with the analyst consensus call for $3.32 billion, according to FactSet. While fiscal second-quarter earnings were unspectacular, the company raised its fiscal year net sales guidance to $13.46 billion to $13.57 billion from $13.4 billion to $13.55 billion.
The expansion will add nearly 1,000 advanced manufacturing jobs and increase Wiwynn’s Texas workforce to more than 2,500 as Amazon ramps up domestic data-center infrastructure.
Core & Main (NYSE:CNM) reported higher fiscal 2026 second-quarter sales, adjusted EBITDA and adjusted earnings per share, supported by municipal infrastructure activity, treatment plant projects, fire protection demand and growing data center-related work. Second-quarter net sales rose 2.5% yea
Markets remain under pressure as geopolitical and economic risks rise. Defensive ETFs could help investors navigate volatility without abandoning growth.
Fast Company has announced its eighth annual Best Workplaces for Innovators list, recognizing businesses that are creating cultures where innovation can thrive at every level. Caylent earned a spot as a winner in the Emerging Enterprise: 201–999 Employees category. Caylent's recognition reflects a year of deliberate investment in employee-led innovation.
Omnicom (NYSE: OMC), the world's leading marketing and sales company, today announced that Troy Ruhanen, President and Chief Executive Officer of Omnicom Advertising, has decided to retire following a distinguished career spanning more than twenty years in leadership roles across Omnicom. Ruhanen's decision follows the successful integration of Omnicom Advertising after the combination of Omnicom and Interpublic, which established a strong foundation for the future.
SandboxAQ announced it has successfully completed the world's first reported test of a magnetic navigation (MagNav) system on an attritable platform – Northrop Grumman's Lumberjack®, a Group 3 UAS attritable drone. It was also the world's first reported instance of a MagNav system being paired with a visual navigation system on an attritable, one-way attack platform. SandboxAQ has collaborated with Northrop Grumman (NYSE: NOC) to integrate and test its commercial, dual-use, AQNav MagNav technolo
Qtonic Quantum today announced that Gina Fratarcangeli has joined the company as Senior Advisor, AI Transformation and Global Alliances. The former Google Managing Director will advise on enterprise adoption, commercial strategy and partnerships with global systems integrators and cloud providers, helping connect Qtonic Quantum's cybersecurity capabilities with the organizations and partners responsible for putting them to work.
Zacks.com users have recently been watching Starbucks (SBUX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Texas Instruments (TXN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Three exceptional Oregon students have been awarded Tech Mastery Scholarships from Rentec Direct as they pursue technology degrees and prepare for careers in high-demand fields. The 2026 recipients represent the next generation of technology leaders and the latest class of students supported through Rentec Direct's decade-long investment in developing Oregon's future tech workforce.
Joins other honorees such as Anthropic, Chipotle, American Express, and many othersCAMBRIDGE, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Fast Company today announced its eighth annual Best Workplaces for Innovators list, recognizing businesses that are creating cultures where innovation can thrive at every level. ReversingLabs earned a spot at No. 49 for its commitment to free-flowing innovation exploration and listening that has ultimately fueled the company's position as a leader in software su
Analog Devices, Inc. (NASDAQ: ADI) and Alif Semiconductor today announced that they have entered into a definitive agreement under which ADI will acquire Alif in an all-cash transaction for $1.35 billion.
Live Nation Entertainment (NYSE:LYV) has outperformed the market over the past 15 years by 9.0% on an annualized basis producing an average annual return of 22.05%. Currently, Live Nation Entertainment has a market
Records from September 8, 2026 indicate that Representative Lloyd Doggett of Texas made a purchase of Procter & Gamble (NYSE:PG), valued between $1,001 and $15,000, with the transaction dated August 17, 2026 and
CEO Cristiano Amon is betting that Qualcomm's next act goes far beyond mobile technology. From grocery stores that bring the physical world online to breakthroughs in 6G, robotics, and data centers, Amon is leading the company into a future built on its innovation tradition.
Qedma Quantum Computing, a pioneer in quantum error reduction software, together with the HQC2 team at University of Copenhagen (KU), Denmark, Technical University of Denmark (DTU) and University of Southern Denmark (SDU), today published the findings of a collaborative study that delivered accurate quantum chemistry results, demonstrating the value of error mitigation in quantum computation. Qedma's researchers will be presenting this work and a separate talk on quantum advantage at Q2B Copenha
CD&R (or the "Firm") today announced the appointment of Giovanni Caforio as an Operating Advisor to CD&R funds. The Firm believes his 35-year career in the international biopharmaceutical industry will be invaluable as he supports CD&R funds in identifying and evaluating new investment opportunities within healthcare, as well as working with its portfolio companies globally.